Smoothing the journey to market

Avoid the risks involved with clinical and commercial milestones. We’ll formulate a clear plan for developing the chemistry, manufacturing, and control (CMC) of your peptide and oligonucleotide drug substances.

Years of interactions with regulatory authorities and sponsors around the world have gone into our general plan (below). But we’ll tailor the exact plan to precisely fit your needs – and your product.

Innovating for you

Innovation is part of our DNA and is more important now than ever, as it’s common to see modified or augmented peptide constructs. Peptides with unnatural amino acids, PEGylation, lipidation, glycosylation, imaging agents and structural constraint, are just few examples of what we encounter with today’s peptide-based entities.

We practise innovation by optimizing our supply chain, manufacturing unnatural amino acid derivatives in-house and meticulous characterization at intermediate stages. We also carefully evaluate peptide synthesis methodology, including liquid phase peptide synthesis, solid phase peptide synthesis or hybrid approaches.

Your business and products will also benefit from our toolbox of pioneering commercial manufacturing technology for peptides. From modern synthetic innovations like Molecular Hiving™ to continuous chromatography technology and an eco-conscious overall process, our approach is cutting edge.

Plus, our research committee is constantly evaluating new trends and technologies, and collaborating with academic groups and industry non-profits. So you’ll benefit from the very latest thinking and practices in peptides.

Contact us